Abstract. Release factors participate in release of fMet from fIIet-tRNA-AUG * ribosome intermediates upon binding to ribosomes. This release requires R factor and occurs in the absence of terminator codon in reactions containing 20 per cent ethanol. Release occurs only when both 30S and 50S ribosomal subunits are present and when fMet-tRNA is located in the ribosomal P site. Release factor-dependent deacylation of fMet-tRNA is inhibited by sparsomycin, amicetin, lincocin, and chloramphenicol, antibiotics which have little effect on binding of R factor to ribosomes. The possible role of peptidyl transferase in the release reaction is discussed.
Introduction. Peptide chain termination consists of at least two events which can now be studied independently: terminator codon recognition and peptide release. In vitro release of fmethionine from fMet-tRNA -AUG -ribosome intermediates requires one of three terminator codons and its corresponding protein release factor, R1 (UAA or UAG) or R2 (UAA or UGA).1 2 More recently R1 and R2 were found to bind to ribosomes with this same codon specificity. 3 We report in this communication conditions which permit R factor to mediate peptide release independent of terminator codon and investigate the ribosomal subunit4 and site requirements5 for peptide release.
Materials and Methods. Preparation of ribosomes and protein factors: Escherichia coli B or MRE 600 ribosomes washed in 1.0 M ammonium chloride were prepared as described previously.6 Ribosomal subunits from MRE 600 ribosomes were isolated by sucrose gradient centrifugation.7 Initiation factors F1 and F2 were partially purified from the 1.0 M ammonium chloride wash of MRE 600 ribosomes by DEAE-cellulose column chromatography.8 The F1 preparation, which was free of R factor activity, was heated at 65°C for 10 min prior to use in order to inactivate an enzyme responsible for deacylation of fMet-tRNA.9 Purified release factors R1 (Fraction VI) and R2 (Fraction VII); transfer factors Ts, Tu, and G, and stimulatory protein (S) were prepared as previously described. Results. Ribosomal subunit requirements for codon-directed release: The ribosomal subunit requirements for peptide chain termination are examined in two ways. In the first instance, f [3H ]Met-tRNA is bound to 30S, and 30S + 50S ribosomal subunits by AUG in the presence of partially purified initiation factors and GTP. In reactions containing UAG and R1 (Fig. 1) , release of fmethionine occurs only when both 30S and 50S ribosomal subunits are present; no release occurs from the fMet-tRNA AUG 308 ribosome intermediate alon&.
Similar results were obtained with R2 and UGA. The small amount of release occurring with 50S subunits alone is due to a 5 per cent contamination with 30S ribosomes. Since fMet-tRNA does not bind to 50S subunits under these con- (Table 1) . No release is observed in the absence of 30S ribosomes although polyphenylalanyl-tRNA-50S ribosomal intermediates are reactive with puromycin, as demonstrated previously.11 These results indicate that both ribosomal subunits are required for codon-directed peptide releage. The ribosomal site requirements for peptide chain termination is investigated by an alternate approach. Neither fMet release nor fMet-puromycin formation occur when fMet-tRNA is bound to ribosomes at 5 mM M\1g++ in the presence of GOPOPCP and initiation factors (Fig. 2) . Both processes do occur, however, when GTP is substituted for GOPOPCP. 16 These results indicate that peptidyl-tRNA must be in the ribosomal P site for both peptide release and peptide bond formation. Control studies assured that GOPOPCP does not inhibit peptide release. Release of fMet independent of codon recognition: Both R1 and R2 promote the release of fMet without terminator codon (Fig. 3) The requirements for codon-independent release are shown in Table 2 . Formyl-methionine release is dependent upon release factor, ribosomes, and ethanol. Thus fMet release can occur in the absence of initiator (AUG) and terminator codons if reactions contain ethanol. Monroe has previously shown an interaction of fl\let-tRNA with the P site of the 50S ribosomal subunit in reactions containing ethanol.'7 Ethanol stimulates the formation of an R. ribosome intermediate, as shown in Table 3 , suggesting that it eliminates the requirement for trinucleotide codons in promoting formation of an R-ribosome fMet-tRNA intermediate. It is unresolved whether ethanol has additional effects in the release reaction. In other studies,5 codon-independent release of fMet was shown to be specific for R1 and R2 and was not found with other protein factors involved in peptide chain elongation (Tu, Ts, G) or termination (8) . Release activity determined either in the presence of ethanol or terminator codon was identical in column fractions containing R1 (Fraction VI) and R2 (Fraction V). Since cruder preparations of release factor contain tRNA and components that inhibit codon-independent release, this method has not been used for purification of R. Only purified R1 or R2 have been used in the reported studies.
In an earlier report"3 it was demonstrated that tRNA added to these reactions results in the formation of fMet-ethyl ester. Purified R1 and R2 release only fMet, not fMet-ethyl ester (Table 4) , and do not convert fMet-ethyl ester to fMet (unpublished data). Electrophoretic analysis of the products of the codon-independent release reaction reveals only fMet.
The ribosomal subunit requirements for the codon-independent release reaction are shown in Table 5 . Release occurs only when both 30S and 50S ribosomes are present. Thus the ribosomal requirements for codon-directed and codon-independent release are identical and differ from the formation of fMet-puromycin (Table 5 ) and fMet-ethyl ester13 which occur with 50S subunits alone.
Antibiotic inhibition of codon-independent release and terminator codon recognition by RI: Codon-independent release of fMet with R1 and ribosomal binding of UA[3H]G by R1 measure two aspects of chain termination and are differentially affected by antibiotics. As shown in Table 6 , sparsomycin, terminator codon ribosome intermediate. 3 In this communication, the hydrolysis of fMet-tRNA in the absence of terminator codons is shown to require R factor, ribosomes, and ethanol and is suggested to occur via an R ribosome -fMet-tRNA intermediate. Release factor, therefore, initially binds to ribosomes upon codon recognition3 and subsequently participates in peptidyl-tRNA hydrolysis. The inhibition of UA [3H]G binding to ribosomes by tetracycline and streptomycin suggests that terminator codon recognition occurs at the 30S ribosomal A site. '9 The release of peptides may occur by one of several mechanisms. Since R factors are proteins, they may directly catalyze release of peptides. Alternately, release factors may activate and/or interact with a ribosomal constituent that catalyzes the hydrolytic event. Peptidyl transferase, a 50S ribosomal subunit enzyme, can catalyze formation of peptide bonds or under special conditions, ester bonds.'3 On the basis of these observations we suggested that the function of peptidyl transferase was to facilitate nucleophilic attack on ribosomal bound peptidyl-tRNA, usually resulting in peptide bond formation. Peptide release could result from nucleophilic attack on peptidyl-tRNA if the nucleophile were a hydroxyl (OH-) group. Peptide release and peptidyl transferase activities share common characteristics apart from these theoretical considerations: both are inhibited by sparsomycin, amicetin, lincocin, and chloramphenicol;'8 and peptidyl-tRNA must be located in the ribosomal P site for either release or peptide bond formation. Although these studies and observations by others2" indirectly suggest that peptidyl transferase participates in peptide chain termination, they do not explain why in reactions containing ethanol and R, where the preferred nucleophile is ethanol not hydroxyl (OH-), the product of the reaction is fMet not formyl-methionyl-ethyl ester. One possible explanation is that protein release factors participate enzymatically in the hydrolytic reaction. Available information does not permit a definitive statement on the mechanism of peptide release at this time, but the methods described in this communication provide an experimental approach to the problem. 
